• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TSAO-T的新型3'-螺核苷类似物。第二部分。基于溶液中核磁共振构象分析和理论计算的比较研究。

Novel 3'-spiro nucleoside analogues of TSAO-T. Part II. A comparative study based on NMR conformational analysis in solution and theoretical calculations.

作者信息

Alvarez R, Jimeno M L, Gago F, Balzarini J, Pérez-Pérez M J, Camarasa M J

机构信息

Instituto de Química Médica (CSIC), Madrid, Spain.

出版信息

Antivir Chem Chemother. 1998 Jul;9(4):333-40.

PMID:9875412
Abstract

The structures of two novel 3'-spiro nucleosides analogues of the potent human immunodeficiency virus type 1 (HIV-1) reverse trancriptase (RT) inhibitor TSAO-m3T, in solution, as derived from NMR spectroscopy are described. In these TSAO analogues the spiro amino oxathioledioxide moiety has been replaced by spiro amino oxazolone or spiro amino oxathiazoledioxide moieties. A comparative study based on theoretical calculations of the hydrophobicity, the solvation free energies and molecular electrostatic potentials (MEP) of the three compounds is also described. No significant conformational differences were detected in solution between TSAO-m3T and its analogues that might account for the differences observed in their inhibitory activity against HIV-1 RT. The calculated hydrophobicity (log P) values, dipole moments and the electrostatic contributions to the solvation free energies of the three spiro ring systems were also similar. However, the differences found in the calculated MEPs of the spiro systems between TSAO-m3T and its analogues suggest that the different electrostatic surroundings of the 4"-amino group of the spiro moiety in the analogues may be responsible for a detrimental electrostatic interaction of the spiro rings with the Glu-B138 of RT.

摘要

描述了两种新型3'-螺核苷类似物在溶液中的结构,它们是强效人类免疫缺陷病毒1型(HIV-1)逆转录酶(RT)抑制剂TSAO-m3T的类似物,结构由核磁共振光谱得出。在这些TSAO类似物中,螺氨基氧硫杂二氧化物部分已被螺氨基恶唑酮或螺氨基氧噻二唑二氧化物部分取代。还描述了基于这三种化合物的疏水性、溶剂化自由能和分子静电势(MEP)理论计算的比较研究。在溶液中未检测到TSAO-m3T与其类似物之间存在可能解释其对HIV-1 RT抑制活性差异的显著构象差异。计算出的三种螺环系统的疏水性(log P)值、偶极矩以及对溶剂化自由能的静电贡献也相似。然而,TSAO-m3T与其类似物之间螺环系统计算出的MEP差异表明,类似物中螺部分4''-氨基的不同静电环境可能导致螺环与RT的Glu-B138发生有害的静电相互作用。

相似文献

1
Novel 3'-spiro nucleoside analogues of TSAO-T. Part II. A comparative study based on NMR conformational analysis in solution and theoretical calculations.TSAO-T的新型3'-螺核苷类似物。第二部分。基于溶液中核磁共振构象分析和理论计算的比较研究。
Antivir Chem Chemother. 1998 Jul;9(4):333-40.
2
Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.TSAO-T的无碱基类似物作为特异性抑制HIV-1逆转录酶的首批糖类衍生物。
J Med Chem. 1998 Nov 5;41(23):4636-47. doi: 10.1021/jm980370m.
3
"Second generation" of TSAO compounds directed against HIV-1 TSAO-resistant strains.针对HIV-1 TSAO耐药菌株的“第二代”TSAO化合物。
Nucleosides Nucleotides Nucleic Acids. 2001 Apr-Jul;20(4-7):707-10. doi: 10.1081/NCN-100002356.
4
Computational analysis of aza analogues of [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranose]-3'-spiro-5"-(4"-amino-1",2"-oxathiole-2",2"-dioxide) (TSAO) as HIV-1 reverse transcriptase inhibitors: relevance of conformational properties on the inhibitory activity.[2',5'-双-O-(叔丁基二甲基甲硅烷基)-β-D-呋喃核糖]-3'-螺-5"-(4"-氨基-1",2"-氧硫杂环戊烯-2",2"-二氧化物)(TSAO)的氮杂类似物作为HIV-1逆转录酶抑制剂的计算分析:构象性质对抑制活性的相关性。
J Chem Inf Model. 2006 Jul-Aug;46(4):1666-77. doi: 10.1021/ci0600410.
5
An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase.一种合成潜在金属螯合TSAO-T衍生物作为1型人类免疫缺陷病毒逆转录酶双齿抑制剂的方法。
Antivir Chem Chemother. 1998 Sep;9(5):413-22.
6
Discovery of TSAO derivatives with an unusual HIV-1 activity/resistance profile.发现具有异常HIV-1活性/耐药性特征的TSAO衍生物。
Antiviral Res. 2006 Aug;71(1):15-23. doi: 10.1016/j.antiviral.2006.02.009. Epub 2006 Mar 29.
7
Human immunodeficiency virus type 1-specific [2',5'-bis-O-(tert- butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"- oxathiole-2",2"-dioxide)-purine analogues show a resistance spectrum that is different from that of the human immunodeficiency virus type 1-specific non-nucleoside analogues.1型人类免疫缺陷病毒特异性的[2',5'-双-O-(叔丁基二甲基甲硅烷基)-β-D-呋喃核糖基]-3'-螺-5"-(4"-氨基-1",2"-氧硫杂环戊二烯-2",2"-二氧化物)-嘌呤类似物显示出与1型人类免疫缺陷病毒特异性非核苷类似物不同的耐药谱。
Mol Pharmacol. 1993 Jan;43(1):109-14.
8
Novel [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]- 3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2" -dioxide) derivatives with anti-HIV-1 and anti-human-cytomegalovirus activity.具有抗HIV-1和抗人巨细胞病毒活性的新型[2',5'-双-O-(叔丁基二甲基甲硅烷基)-β-D-呋喃核糖基]-3'-螺-5''-(4''-氨基-1'',2''-氧硫杂环戊烯-2'',2''-二氧化物)衍生物
J Med Chem. 2005 Feb 24;48(4):1158-68. doi: 10.1021/jm040868q.
9
Improving the antiviral efficacy and selectivity of HIV-1 reverse transcriptase inhibitor TSAO-T by the introduction of functional groups at the N-3 position.通过在N-3位引入官能团提高HIV-1逆转录酶抑制剂TSAO-T的抗病毒效力和选择性。
J Med Chem. 2005 Oct 20;48(21):6653-60. doi: 10.1021/jm050437n.
10
Identification of a putative binding site for [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine (TSAO) derivatives at the p51-p66 interface of HIV-1 reverse transcriptase.在HIV-1逆转录酶的p51-p66界面鉴定[2',5'-双-O-(叔丁基二甲基甲硅烷基)-β-D-呋喃核糖基]-3'-螺-5''-(4''-氨基-1'',2''-氧硫杂环戊烯-2'',2''-二氧化物)胸腺嘧啶(TSAO)衍生物的假定结合位点。
J Med Chem. 2001 Jun 7;44(12):1853-65. doi: 10.1021/jm001095i.

引用本文的文献

1
Crystal structure of tert-butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in complex with HIV-1 reverse transcriptase (RT) redefines the elastic limits of the non-nucleoside inhibitor-binding pocket.叔丁基二甲基硅基螺环氨基氧硫代二氧噻嗪-胸腺嘧啶(TSAO-T)与 HIV-1 逆转录酶(RT)复合物的晶体结构重新定义了非核苷抑制剂结合口袋的弹性极限。
J Med Chem. 2011 Apr 28;54(8):2727-37. doi: 10.1021/jm101536x. Epub 2011 Mar 29.